PT  - JOURNAL ARTICLE
AU  - Di Pietro, R.
AU  - Basile, M.
AU  - Antolini, L.
AU  - Alberti, S.
TI  - Genetic drift and environmental spreading dynamics of COVID-19
AID  - 10.1101/2020.05.08.20095448
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.08.20095448
4099  - http://medrxiv.org/content/early/2020/05/12/2020.05.08.20095448.short
4100  - http://medrxiv.org/content/early/2020/05/12/2020.05.08.20095448.full
AB  - Objective To delineate the genetic and environmental determinants of COVID-19 spreading.Design Retrospective case series.Setting Spain, Italy, Sweden, Finland, Norway.Participants All laboratory-confirmed infection cases (n=168,089) collected from February 21st to April 14th 2020.Main outcome measures Infection spreading velocity according to viral mutation load and to climate region.Results The mean doubling time of COVID-19 was 6.63 days in northern Italy, 5.87 days in central areas, and 5.38 days in southern Italy, with shorter COVID-19 doubling time in warmer regions. Spain extended this trend, with a mean COVID-19 doubling time of 4.2 days. At the other end of the spectrum, slower diffusion across progressively colder regions was observed in Scandinavia, with 9.4 days COVID-19 doubling time in Sweden, 10.8 days in Finland and 12.95 days in Norway. Mutations and mutation rates of SARS-CoV-2 versus COVID-19 spreading were analyzed worldwide. Models of increased aggressiveness of SARS-CoV-2 upon progressive acquisition of genetic changes were not supported by regional mutation data.Conclusion Current propagation models suggest dependence of COVID-19 pandemic spreading on wintertime conditions, with expected waning over the summer. Our findings indicate association of COVID-19 to a sharp North/South climate gradient, with faster spreading in southern regions. Thus, warmer climate conditions may not limit SARS-CoV-2 diffusion. Very cold regions may be better spared by recurrent courses of infection.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno funding was provided to this researchAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data referred to in the manuscript are available as needed